Kaiser Permanente-backed respiratory device provider Vapotherm floated at the bottom of its range but raised $56m in its initial public offering.
Vapotherm, a US-based medical device developer that counts healthcare provider Kaiser Permanente as an investor, secured $56m in an initial public offering on the New York Stock Exchange yesterday.
The company issued 4 million shares priced at $14.00 each, at the foot of the IPO’s $14 to $16 range, valuing it at about $234m. They opened at $15.50 yesterday and closed at $16.00.
Founded in 1999, Vapotherm produces devices that treat respiratory distress by delivering heated, humidified and oxygenated…
